STAT3 in Prostate Cancer: Whom Should We Treat and When?

被引：7
作者：
Culig, Zoran [1 ]
机构：
[1] Med Univ Innsbruck, Dept Urol, Expt Urol, Anichstr 35, A-6020 Innsbruck, Austria
来源：
EUROPEAN UROLOGY | 2017年 / 71卷 / 03期
关键词：
INTERLEUKIN-6; CELLS; ANTIBODY; GROWTH; MICE;
D O I：
10.1016/j.eururo.2016.06.034
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：317 / 318
页数：2
相关论文
共 10 条
  • [1] EC-70124, a Novel Glycosylated Indolocarbazole Multikinase Inhibitor, Reverts Tumorigenic and Stem Cell Properties in Prostate Cancer by Inhibiting STAT3 and NF-κB
    Civenni, Gianluca
    Longoni, Nicole
    Costales, Paula
    Dallavalle, Cecilia
    Inclan, Cristina Garcia
    Albino, Domenico
    Nunez, Luz Elena
    Moris, Francisco
    Carbone, Giuseppina M.
    Catapano, Carlo V.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2016, 15 (05) : 806 - 818
  • [2] Expression of STAT3 in Prostate Cancer Metastases
    Don-Doncow, Nicholas
    Marginean, Felicia
    Coleman, Ilsa
    Nelson, Peter S.
    Ehrnstrom, Roy
    Krzyzanowska, Agnieszka
    Morrissey, Colm
    Hellsten, Rebecka
    Bjartell, Anders
    [J]. EUROPEAN UROLOGY, 2017, 71 (03) : 313 - 316
  • [3] Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer
    Dorff, Tanya B.
    Goldman, Bryan
    Pinski, Jacek K.
    Mack, Philip C.
    Lara, Primo N., Jr.
    Van Veldhuizen, Peter J., Jr.
    Quinn, David I.
    Vogelzang, Nicholas J.
    Thompson, Ian M., Jr.
    Hussain, Maha H. A.
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (11) : 3028 - 3034
  • [4] JAK-STAT Blockade Inhibits Tumor Initiation and Clonogenic Recovery of Prostate Cancer Stem-like Cells
    Kroon, Paula
    Berry, Paul A.
    Stower, Michael J.
    Rodrigues, Greta
    Mann, Vincent M.
    Simms, Matthew
    Bhasin, Deepak
    Chettiar, Somsundaram
    Li, Chenglong
    Li, Pui-Kai
    Maitland, Norman J.
    Collins, Anne T.
    [J]. CANCER RESEARCH, 2013, 73 (16) : 5288 - 5298
  • [5] IL-6 Overexpression in ERG-Positive Prostate Cancer Is Mediated by Prostaglandin Receptor EP2
    Merz, Constanze
    von Maessenhausen, Anne
    Queisser, Angela
    Vogel, Wenzel
    Andren, Ove
    Kirfel, Jutta
    Duensing, Stefan
    Perner, Sven
    Nowak, Michael
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2016, 186 (04) : 974 - 984
  • [6] TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells
    Moreira, Dayson
    Zhang, Qifang
    Hossain, Dewan Md S.
    Nechaev, Sergey
    Li, Haiqing
    Kowolik, Claudia M.
    D'Apuzzo, Massimo
    Forman, Stephen
    Jones, Jeremy
    Pal, Sumanta K.
    Kortylewski, Marcin
    [J]. ONCOTARGET, 2015, 6 (19) : 17302 - 17313
  • [7] STAT3 regulated ARF expression suppresses prostate cancer metastasis
    Pencik, Jan
    Schlederer, Michaela
    Gruber, Wolfgang
    Unger, Christine
    Walker, Steven M.
    Chalaris, Athena
    Marie, Isabelle J.
    Hassler, Melanie R.
    Javaheri, Tahereh
    Aksoy, Osman
    Blayney, Jaine K.
    Prutsch, Nicole
    Skucha, Anna
    Herac, Merima
    Kraemer, Oliver H.
    Mazal, Peter
    Grebien, Florian
    Egger, Gerda
    Poli, Valeria
    Mikulits, Wolfgang
    Eferl, Robert
    Esterbauer, Harald
    Kennedy, Richard
    Fend, Falko
    Scharpf, Marcus
    Braun, Martin
    Perner, Sven
    Levy, David E.
    Malcolm, Tim
    Turner, Suzanne D.
    Haitel, Andrea
    Susani, Martin
    Moazzami, Ali
    Rose-John, Stefan
    Aberger, Fritz
    Merkel, Olaf
    Moriggl, Richard
    Culig, Zoran
    Dolznig, Helmut
    Kenner, Lukas
    [J]. NATURE COMMUNICATIONS, 2015, 6
  • [8] Regulation of growth of prostate cancer cells selected in the presence of interleukin-6 by the anti-interleukin-6 antibody CNTO 328
    Steiner, Hannes
    Cavarretta, Ilaria T.
    Moser, Patrizia L.
    Berger, Andreas P.
    Bektic, Jasmin
    Dietrich, Hermann
    Zaki, Mohamed H.
    Nakada, Marian
    Hobisch, Alfred
    Nemeth, Jeffrey A.
    Culig, Zoran
    [J]. PROSTATE, 2006, 66 (16) : 1744 - 1752
  • [9] Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice
    Wallner, L
    Dai, JL
    Escara-Wilke, J
    Zhang, J
    Yao, Z
    Lu, Y
    Trikha, M
    Nemeth, JA
    Zaki, MH
    Keller, ET
    [J]. CANCER RESEARCH, 2006, 66 (06) : 3087 - 3095
  • [10] Interleukin-6 inhibits the growth of prostate cancer xenografts in mice by the process of neuroendocrine differentiation
    Wang, QC
    Horiatis, D
    Pinski, J
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (04) : 508 - 513
1